XRP ETF Approval Looms: Top Rivals Poised for 100x Gains

The U.S. Securities and Exchange Commission (SEC) has acknowledged filings submitted by Bitwise, Grayscale, and 21Shares for a spot XRP exchange-traded fund (ETF), bringing the approval closer. While this bodes well for XRP's price, crypto traders are looking for top XRP rivals that could outperform it and potentially rally by 100 times ahead of the ETF's 21-day deadline.

This analysis explores three of the best XRP rivals that could experience explosive 100x gains in the event of an XRP ETF approval. These coins are poised to benefit from XRP's rally and have strong fundamentals and catalyst news that could spark a significant jump in the coming months.

Stellar (XLM) is one of Ripple's greatest rivals in the crypto payments industry and has experienced an impressive rally in late 2024, with the price increasing by more than 500% between November and December. This suggests that Stellar could experience a 100x gain if the SEC approves an XRP ETF. At the time of writing, XLM traded at $0.33 after a 4% drop, but its market dominance remains strong, ranking it as the 14th largest crypto by market capitalization. Despite the price decline, XLM's on-balance volume (OBV) remains elevated, indicating that demand for the token has not dried up. If buying sentiment persists, XLM could aim for the 161.8% Fibonacci level at $0.87.

Dogecoin (DOGE) is another major XRP rival to consider. Unlike XRP, DOGE has a clear regulatory standing with the SEC, making it likely that its ETF could receive approval sooner. At press time, Dogecoin traded at $0.24, with bearish pressure leading to a 5% decline in 24 hours. However, DOGE price continues to trade within an ascending parallel channel on the weekly chart, indicating a likelihood of a bullish continuation. According to analyst Ali Charts, DOGE needs to hold support between the $0.16 and $0.19 price levels. If this support can hold, the Dogecoin price prediction suggests a rally towards $3, making it one of the top XRP competitors to buy for 100x gains